2010年跨国制药企业业绩

来源 :上海食品药品监管情报研究 | 被引量 : 0次 | 上传用户:yingq
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
尽管世界经济已在缓慢恢复,但不确定的因素仍然很多,而且新的问题也可能再次影响世界经济发展。制药行业仍然没有恢复到20世纪80-90年代最辉煌时代,有人认为制药行业已经不再是朝阳行业,而生物技术仍然是企业发展的动力,治疗诸如癌症、关节炎以及其他过去无法治疗的疾病,特别是过去的罕见病、今天的常见病。跨国制药企业当前的对策,除了进行研发新 Although the world economy is slowly recovering, there are still many uncertainties and new issues may once again affect the world economic development. The pharmaceutical industry still has not returned to the brightest times of the 1980s and 1990s. Some people think that the pharmaceutical industry is no longer a sunrise industry and that biotechnology is still the driving force behind the development of the business, such as cancer, arthritis and other previously untreatable diseases , Especially the rare diseases of the past, the common diseases of today. Current strategies of multinational pharmaceutical companies, in addition to new research and development
其他文献